Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from UBS

Why You Can't Trust Friday's Jobs Report, And What It Means For The S&P 500

Recent monthly jobs reports are stretching credulity. Evidence suggests recession may be close at hand.

Investors Business Daily

Why Amgen's Cancer Drug Results Gave This Small Cap A Big Boost

Amgen stock jumped Wednesday after outperforming expectations in a lung-cancer study. It brought rival Mirati along for the ride.

Investors Business Daily

Salesforce Faces Price Target Cuts On Guidance Cut, Shares Slide

Salesforce Inc (NYSE: CRM) reported upbeat results for its second quarter, but lowered its annual projections.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Could Target and Walmart Be Beneficiaries From A Bed Bath & Beyond Bankruptcy?

Retail giants Target Corporation (NYSE: TGT) and Walmart Inc (NYSE: WMT) might gain some market share inadvertently and could be the unintended beneficiary of the looming bankruptcy risk for the retail cha

Benzinga

IBD Stock Of The Day AstraZeneca Stalls As Gilead Looks To Take Its Breast Cancer Market

AstraZeneca is the IBD Stock Of The Day amid growing enthusiasm for its cancer drug, Enhertu. But AZN stock hit resistance Monday.

Investors Business Daily

Bank of England’s dire recession warning too ‘optimistic’ amid gas threat, economists say

‘If Russia were to completely cut supplies and we had a cold winter it would be a perfect storm’

The Independent UK

Growth Stocks Have Rallied. Don't Go Too Nuts for Them, UBS Says.

The Russell 1000 Growth index has soared 18% since June 16, compared to a 9% rise for the Russell 1000 Value index.

The Street

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022

Upgrades

Benzinga

Gucci’s Sales Growth Eases in Q2 as China Lockdowns Weigh

Gucci's sales growth eases in Q2 as China lockdowns weigh Sales at French luxury group Kering's top brand Gucci rose by just 4% in the second quarter, the group said on Wednesday, as a new round of lockdowns weighed on revenues in the key Chinese market. Overall sales for Kering,…

Asharq Al-Awsat

Walmart To $142? Plus This Analyst Raises Price Target On McDonald's

Keybanc raised the price target for McDonald's Corporation (NYSE: MCD) from $285 to $290. However, Keybanc analyst Eric Gonzalez maintained the stock with an Overweight rating. McDonald's shares fell 0.3% to $256.23 in pre-market trading.

Benzinga

LVMH Q2 Sales Climb 19%, Offsetting Slower China

Sales at LVMH, the world's largest luxury group, rose by 19% in the three months to June, as robust growth in the US and China helped it offset a new round of lockdowns in China. LVMH, which owns dozens of high-end labels such as Tiffany, said sales came to 18.73…

Asharq Al-Awsat

Stock Rally Doesn't Have Much Staying Power: UBS

Equities have rebounded recently, with the S&P 500 up 8% since June 16, as investors have been bottom-fishing.

The Street

This Healthcare Stock Jumped 110%; Here Are 64 Biggest Movers From Yesterday

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares climbed 264% to close at $18.20 on Thursday. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

Benzinga

Why Is Super Micro Computer Higher By More Than 13%? 42 Stocks Moving In Thursday's Mid-Day Session

Gainers Virax Biolabs Group Limited (NASDAQ: VRAX) shares jumped 364.3% to $23.22. The company offered shares at an expected price of $5.00 per share with an insider lock-up period of 180 days ending on January 17, 2023.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

American tourists splurge in Paris boutiques as euro slides

American tourist Shawna Wilson says she has splashed out on four dresses at the high-end LVMH-owned department store La Samaritaine in Paris, tempted by the prices as the euro reached parity with the U.S. dollar.

Bangkok Post

UBS, Citi among banks hit by Asia rich clients’ pullback

A slump in client trading activity in Asia is threatening to slow a lucrative earner for the world’s biggest wealth managers.

Reuters

Criminal complaint filed against UBS over DRC-linked funds

Three organisations have filed a criminal complaint to federal prosecutors in Switzerland, alleging a failure to exercise due diligence at UBS in relation to funds they say were received by an alleged associate of former Congolese president Joseph Kabila.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

This Analyst Lowers Price Targets On Visa, Mastercard, American Express; Here's The Biggest Price Target Changes For Wednesday

UBS cut Moelis & Company (NYSE: MC) price target from $54 to $40. Moelis shares rose 3% to close at $40.84 on Tuesday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2022

Upgrades

Benzinga

UBS Maintains Buy Rating for Lennar: Here's What You Need To Know

UBS has decided to maintain its Buy rating of Lennar (NYSE:LEN) and lower its price target from $108.00 to $106.00. Shares of Lennar are trading up 2.7% over the last 24 hours, at $67.42 per share. A move to $106.00 would account for a 57.22% increase from the current share…

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2022

Upgrades

StockNews.com

2 Non-Energy Stocks Pushing Up Against Their 52-Week Highs

Energy prices have risen amid tight supplies and robust demand. The industry tailwinds have helped several energy stocks to gain substantially this year. However, looking beyond the energy sector, a few stocks are pushing up against their 52-week highs. Two such non-energy stocks, Kronos Worldwide (KRO) and Sanderson Farms (SAFM)…

Benzinga

UBS Maintains Buy Rating for Keysight Technologies: Here's What You Need To Know

UBS has decided to maintain its Buy rating of Keysight Technologies (NYSE:KEYS) and lower its price target from $220.00 to $177.00. Shares of Keysight Technologies are trading up 1.86% over the last 24 hours, at $133.49 per share.

1 … 25 26 27 28

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

International Monetary Fund

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.